Drugs / interferon alfa-2a
interferon alfa-2a
also known as
Alpheon · Canferon · Canferon a · Cha-ifnalpha2a · IFN-α2a · Interferon alfa-2a (genetical recombination) · interferon-a-2a · interferon-α2a · +3 more
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01609010 | Oct 2002 → Jul 2011 | lymphoma | Hoffmann-La Roche | Completed | Missed primary |
Evidence & citations 14 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | interferon alfa-2a | “in combination with Roferon-A (interferon alfa-2a) in patients with follicular or other CD20+ low-grade lymphoma.” NCT01609010 ↗ |
| Known as | Alpheon | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | Canferon | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | Canferon a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | Cha-ifnalpha2a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | IFN-α2a | “rituximab combined with 5 weeks of interferon-α2a (IFN-α2a) (3-4.5 MIU daily) as priming.” PMID 25686644 ↗ Mar 2015 |
| Known as | Interferon alfa-2a (genetical recombination) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | interferon-a-2a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01609010 ↗ |
| Known as | interferon-α2a | “rituximab combined with 5 weeks of interferon-α2a (IFN-α2a) (3-4.5 MIU daily) as priming.” PMID 25686644 ↗ Mar 2015 |
| Known as | Recombinant human interferon-alfa-2a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | RO 22-8181 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Known as | Roferon a | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108508 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2108508 ↗ |
| Route | Subcutaneous | “interferon-a2a subcutaneously (s.c.) during Week 1” NCT01609010 ↗ |